Home › Atopic Dermatitis (Eczema) › Florida
Atopic Dermatitis (Eczema) clinical trials in Florida
17 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in Florida.
Cities in Florida
- Miami8 studies
- Tampa7 studies
- St. Petersburg5 studies
- Miami Gardens4 studies
- Coral Springs4 studies
- Kendall3 studies
- Hollywood3 studies
- Boca Raton3 studies
- Jacksonville3 studies
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
- Novartis Investigative Site, Miami
- Novartis Investigative Site, St. Petersburg
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Sep 28, 2026 · NCT06947993A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
- Solutions Through Advanced Research, Jacksonville
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Sep 25, 2026 · NCT06807281A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
- Gsi Clinical Research, Margate
RecruitingPhase 2
Ages 18 to 64 · All sexes · Updated Sep 25, 2026 · NCT07216027Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Fort Lauderdale
- Enveda Investigative Site, Miami
- Enveda Investigative Site, Miramar
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT07298395A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
- Investigational Site, Coral Gables
- Investigational Site, Jacksonville
- Investigational Site, Margate
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT07003425A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
- Olympian Clinical Research, Tampa
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT07223697A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
- AllerVie Clinical Research, Panama City
- GCP Research , Global Clinical Professionals, St. Petersburg
RecruitingPhase 3
Ages 12 and older · All sexes · Updated Sep 4, 2026 · NCT07765888A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
- ABMED Clinical Research Corp., Cape Coral
- Skin Care Research, Hollywood
- Quality Care Clinical Research, Miami
- and 4 more
RecruitingPhase 2
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
- Inmagene Site 19, Ocala
- Inmagene Site 4, Tampa
RecruitingPhase 2
Ages 18 to 74 · All sexes · Updated Aug 12, 2026 · NCT07037901This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
- St. Jude Clinical Research- Site Number : 8400049, Doral
- Ziaderm Research, LLC- Site Number : 8400021, North Miami Beach
RecruitingObservational study
Ages 12 and older · All sexes · Updated Aug 6, 2026 · NCT07290803A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Pediatric Skin Research - Coral Gables /ID# 266308, Coral Gables
RecruitingPhase 3
Ages 2 to 11 · All sexes · Updated Aug 6, 2026 · NCT06461897A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
- Enveda Investigative Site, Boca Raton
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 6, 2026 · NCT07643766FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- Miami Dermatology and Laser Research, Miami
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 70 · All sexes · Updated Jul 22, 2026 · NCT06564389A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
- Leo Pharma Investigational site, Jacksonville
- Leo Pharma Investigational site, Miami
- Leo Pharma Investigational site, Tampa
RecruitingPhase 3
6 Months – 11 Years · All sexes · Updated Jul 7, 2026 · NCT06311682A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
- Skin Care Research Boca Raton /ID# 263733, Boca Raton
- TrueBlue Clinical Research - Brandon /ID# 265037, Brandon
- Life Clinical Trials - Coral Springs /ID# 267195, Coral Springs
- and 13 more
RecruitingPhase 3
Ages 18 to 63 · All sexes · Updated Jul 6, 2026 · NCT06389136A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
- Revival Research, Doral
- Floridian Research Institute Llc, Miami
- Global Health Research Center, Inc., Miami Lakes
- and 4 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 4, 2026 · NCT05995964Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
- Galderma Investigational Site 8597, Boca Raton
- Galderma Investigational Site 7087, Coral Gables
- Galderma Investigational Site 7063, Cutler Bay
- and 7 more
RecruitingObservational study
Ages 12 and older · All sexes · Updated Mar 13, 2026 · NCT06988605From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.